Kenneth L. Wilson, the Chief Wealth Officer of Cullen/Frost Bankers, Inc., has acquired 2,689 restricted stock units. This acquisition, reported in a recent SEC filing, is significant as it demonstrates Wilson's confidence in the bank's future performance and aligns his interests with those of shareholders.
Cullen/Frost Bankers, headquartered in San Antonio, Texas, is a prominent player in the national commercial banking sector. The bank operates under the ticker symbol CFR and is known for its comprehensive financial services. The company has undergone various name changes over the years, with its most recent being in 1992.
The SEC filing, dated October 29, 2026, indicates that the transaction took place on October 27, 2026. Wilson's acquisition of the restricted stock units was made at a transaction price of $0 per share, highlighting the nature of these units as part of his compensation package. According to the filing, "Each restricted stock unit represents the right to receive one share of Cullen/Frost common stock," further emphasizing the alignment of executive compensation with shareholder interests.
This move may have implications for the bank's stakeholders, including employees, investors, and analysts. By increasing his stake in the company, Wilson may signal a strong belief in Cullen/Frost's strategic direction and financial health. Such actions can influence employee morale and investor confidence, especially in the competitive landscape of national commercial banks.
Details were not available in the SEC filing regarding any upcoming changes or additional transactions. However, the acquisition of restricted stock units by a high-ranking officer like Wilson suggests a positive outlook for Cullen/Frost Bankers in the near future.
Read Next
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Brophy Michael Burkes sells 3,084 shares of Natera stock
Glenbrook Capital Management Boosts Stake in SenesTech
OS Therapies grants stock options to Chief Medical Officer
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Chen Wan-Shan Reports Share Transaction for Belite Bio






